BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7696144)

  • 1. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
    Ho SM; Yu M
    J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
    Ho SM; Yu M
    Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
    Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
    Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate.
    Ghatak S; Oliveria P; Kaplan P; Ho SM
    Prostate; 1996 Aug; 29(2):91-100. PubMed ID: 8700805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
    Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM
    Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
    Ofner P; Bosland MC; Vena RL
    Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats.
    Leav I; Ho SM; Ofner P; Merk FB; Kwan PW; Damassa D
    J Natl Cancer Inst; 1988 Sep; 80(13):1045-53. PubMed ID: 2457709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine.
    Lane KE; Leav I; Ziar J; Bridges RS; Rand WM; Ho SM
    Carcinogenesis; 1997 Aug; 18(8):1505-10. PubMed ID: 9276623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats.
    Leav I; Merk FB; Kwan PW; Ho SM
    Prostate; 1989; 15(1):23-40. PubMed ID: 2477830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of estradiol and estrone in organ cultures of dorsolateral and ventral prostate of untreated and sex hormone-implanted rats.
    Ofner P; Nadeau MR; Vena RL; Leav I
    Steroids; 1992 Feb; 57(2):50-5. PubMed ID: 1621255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor levels and androgen contents in the prostate lobes of intact and testosterone-treated Noble rats.
    Ho SM; Damassa D; Kwan PW; Seto HS; Leav I
    J Androl; 1985; 6(5):279-90. PubMed ID: 3877039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role of testosterone-androgen receptor interactions in mediating masculine sexual behavior in male rats.
    McGinnis MY; Dreifuss RM
    Endocrinology; 1989 Feb; 124(2):618-26. PubMed ID: 2912689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol and high-dose dihydrotestosterone treatment causes changes in cynomolgus monkey prostate volume and histology identical to those caused by testosterone alone.
    Kamischke A; Weinbauer GF; Semjonow A; Lerchl A; Richter KD; Nieschlag E
    J Androl; 1999; 20(5):601-10. PubMed ID: 10520572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats.
    Lane KE; Ricci MJ; Ho SM
    Prostate; 1997 Mar; 30(4):256-62. PubMed ID: 9111603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of [3H]estradiol binding sites in the rat prostate: properties and distribution of type I and type II sites.
    Yu M; Cates J; Leav I; Ho SM
    J Steroid Biochem; 1989 Sep; 33(3):449-57. PubMed ID: 2779236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the balance of sex hormones may affect rat prostatic inflammation and fibrosis, and osteopontin might be involved in this process.
    Cao Y; Zhang H; Tang XH; Tu GL; Tian Y; Luo GH; Wang YD; Wang Z; An LY; Luo MX; Tang L
    Int Urol Nephrol; 2023 Sep; 55(9):2355-2365. PubMed ID: 36890408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
    Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
    Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
    Yatkin E; Bernoulli J; Talvitie EM; Santti R
    Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.
    Ho SM; Leav I; Ghatak S; Merk F; Jagannathan VS; Mallery K
    Am J Pathol; 1998 Jul; 153(1):131-9. PubMed ID: 9665473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of aromatase activity in the rat brain by estradiol and 5 alpha-dihydrotestosterone.
    Roselli CE
    Neuroendocrinology; 1991 Jan; 53(1):79-84. PubMed ID: 2046863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.